2023
DOI: 10.1016/j.nupar.2023.03.153
|View full text |Cite
|
Sign up to set email alerts
|

Analyse intermédiaire de l’efficacité et de la sécurité d’emploi de setmélanotide comme nouveau traitement chez des patients souffrant d’obésité hypothalamique

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles